Andrew R. Carey, MD is a the Neil R. Miller Rising Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa. Dr. Carey’s clinical and research interests include comparative effectiveness and cost-benefit of intravitreal medications, long-term outcome of treatments for choroidal neovascularization, novel treatments for papillitis, and the use of novel imaging modalities to better diagnose and understand optic nerve and retinal diseases. Dr. Carey received his bachelor's from Davidson College in mathematics in 2006. In 2010, he received his medical degree from the University of South Florida. He completed his ophthalmology residency as Chief Resident in 2014 at the University of South Florida. He then went on to complete his fellowship in neuro-ophthalmology at Bascom Palmer Eye Institute in 2015 and his fellowship in medical retina at the University of Iowa in 2016. Videos Dr. Andrew R. CareyNeuro-Ophthalmology. Dr. Carey is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Optic Nerve Atrophy, and Optic Neuritis.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Interstitial Keratitis, Cataract, Optic Nerve Atrophy, Vitrectomy, and Cataract Removal.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Nerve Atrophy.

Dr. Becker is a neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. From there, he completed a year-long fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Becker is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Multiple Sclerosis (MS), Paraplegia, Relapsing Multiple Sclerosis (RMS), and Cerebellar Multiple System Atrophy.

Farhad Naseh is an Ophthalmologist in Gaithersburg, Maryland. Dr. Naseh is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Glaucoma, Optic Atrophy Type 1, Optic Nerve Atrophy, and Hereditary Keratitis. Dr. Naseh is currently accepting new patients.

Dan Yin is an Ophthalmologist in Rockville, Maryland. Dr. Yin is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Interstitial Keratitis, Retinal Vasculopathy with Cerebral Leukodystrophy, Coats Disease, and Familial Exudative Vitreoretinopathy. Dr. Yin is currently accepting new patients.

Arusha Gupta is an Ophthalmologist in Silver Spring, Maryland. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Ocular Hypertension (OHT), and Kallikrein Hypertension. Dr. Gupta is currently accepting new patients.

Gaytri Gupta-Elera is an Ophthalmologist in Gaithersburg, Maryland. Dr. Gupta-Elera has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Dry Eye Syndrome, and Allergic Conjunctivitis. Dr. Gupta-Elera is currently accepting new patients.

Dr. Katz completed his undergraduate degree in Neuroscience at Colgate University, his MD at SUNY/Buffalo School of Medicine (his home town), his Neurology residency at Duke University Medical Center, and his Neuro-Ophthalmology fellowship at the University of Michigan/Kellogg Eye Center. Dr. Katz specializes in Neuro-Ophthalmology and Neurology. Dr. Katz has been a primary investigator in clinical trials in Neuro-Ophthalmology and holds academic appointments at Georgetown University Hospital and Howard University Hospital. A list of his publications can be found on. Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Optic Neuritis, Meningitis, Arachnoiditis, and Temporal Arteritis.

Todd Goodglick is an Ophthalmologist in Chevy Chase, Maryland. Dr. Goodglick is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Optic Neuritis, Horner Syndrome, Eyelid Bump, and Eyelid Drooping.

Prior to joining VED in December, 2017, Dr. Hammer was with Baltimore Washington Eye Center. Dr. Hammer earned his medical degree from the University of Maryland, School of Medicine followed by an Internship at Eisenhower Army Medical Center in Augusta, Georgia. He then completed his training with a residency in Ophthalmology at the Walter Reed Army Medical Center which serves the greater Washington, DC Metro area. Dr. Hammer served as Chief of Ophthalmology at Ireland Community Hospital in Fort Knox, Kentucky. Dr. Hammer enjoys spending time with his family and is very involved with the community. His commitment and his passion for his work is demonstrated by the loyalty of his patients. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Dry Eye Syndrome, Subconjunctival Hemorrhage, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Cataract Removal.

Everardo Hernandez-Quintela, M.D., M.Sc., F.A.C.S. is an accomplished cataract and cornea surgeon at the Wilmer Eye Institute’s locations in Baltimore and Lutherville, Maryland. He specializes in both refractive surgery (LASIK and PRK) and corneal transplant. Dr. Hernández-Quintela is the medical director for Wilmer's Patient Access Center for the Eye (PACE). Prior to joining Johns Hopkins Medicine, Dr. Hernandez Quintela was a professor of ophthalmology at the Universidad Nacional Autónoma de México where he led the course on research methodology in ophthalmology and the advanced course on cornea and refractive surgery. He is the founder of the international chapter of the Association of Research in Vision and Ophthalmology (ARVO) in Mexico, known as Colegio Nacional de Investigación en Ciencias Visuales (MARVO). Dr. Hernández-Quintela is a peer review editorial member of the Journal of the American Academy of Ophthalmology and the International Journal of Ophthalmology among other prestigious journals. He held a clinical academic position as head of cornea and refractive surgery services, and head of research at the Asociación para Evitar la Ceguera en México Hospital in Mexico City, which is one of the largest eye hospitals in Latin America. Dr. Hernández-Quintela began his career at Universidad La Salle and Universidad Nacional Autonoma de Mexico in Mexico City. He performed his residency training at the Asociación para Evitar la Ceguera en México Hospital, in Mexico City, and completed his fellowships at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in the United States with professor Dimitri Azar, and at the Hôtel Dieu Hospital, at Université Paris in France with Professor J.M. Legeais and Prof. Yves Pouliquen.Dr. Hernández-Quintela holds a Master in Science from the Universidad Nacional Autónoma de México, School of Medicine. Dr. Hernandez is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Interstitial Keratitis, Keratoconus, Cataract, Corneal Transplant, and Cataract Removal.

Dr. Henderson is the Frank B. Walsh Professor of Neuro-Ophthalmology at the Wilmer Eye Institute and is the Chief of the Wilmer Neuro-Ophthalmology Division. She attended medical school at Emory University, completed an ophthalmology residency at the Medical College of Georgia, and completed a fellowship in neuro-ophthalmology at the Bascom Palmer Eye Institute. Her research interests include optic neuropathies, specifically non-arteritic anterior ischemic optic neuropathy; high-value care; and the use of big data to answer neuro-ophthalmic questions. She also has a particular interest in medical education and serves as the Associate Ophthalmology Residency Program Director and the Neuro-Ophthalmology Fellowship Director. Dr. Henderson is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Optic Neuritis, Strabismus, Increased Intracranial Pressure, and Optic Atrophy Type 1.

Mona Kaleem, M.D. is an Associate Professor of Ophthalmology at the Wilmer Eye Institute. She is a fellowship trained glaucoma and cataract surgeon in Bethesda, Maryland. She is broadly trained in the medical and surgical care of glaucoma. Her excellence in patient care, teaching, and research activities resulted in her selection to the American Glaucoma Society. She was also selected by her peers as a Baltimore Magazine “Top Doctor” in 2018, 2019 and 2021. In 2020, Dr. Kaleem was honored with the American Academy of Ophthalmology's Achievement Award. Dr. Kaleem was born and raised in Maryland. She earned her Bachelor’s degree in Economics with double minors in Biology and Chemistry at Smith College prior to entering the Howard University College of Medicine. There, she was a Trustee Scholar and awardee of the Malcolm X Scholarship due to her leadership in community service. She completed her medical training at Mercy Medical Center, Howard University Hospital, and the Cleveland Clinic. She has a strong interest in volunteerism and has participated in medical missions globally and in underserved areas within the United States. Dr. Kaleem is also known for her involvement in grass roots legislative efforts that impact the way that ophthalmology care is delivered and received in the United States. She is one of the hosts of the Diagnosis Glaucoma podcast and co-authored the book Glaucoma: What Every Patient Should Know with Dr. Harry Quigley. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Kaleem-cv.pdf. Dr. Kaleem is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Vitrectomy, and Trabeculectomy.

Dr. Cremers anchors the Visionary Eye Doctor team and is a widely respected and experienced researcher and clinician in dry eye disease, having spent a decade at Harvard Medical School and the Massachusetts Eye and Ear infirmary. She is a fellow with the American College of Surgeons, specializing in cataract and pterygium surgery. CV https://www.hopkinsmedicine.org/suburban_hospital/_documents/physician%20CV/cremers-cv.pdf. Dr. Cremers is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Pterygium, Dry Eye Syndrome, Blepharitis, and Glaucoma.

Michael Carper, M.D. is an ophthalmologist in Baltimore, Maryland specializing in diplopia, optic neuropathy, multiple sclerosis and idiopathic intracranial hypertension. He has particular interest in stroke affecting visual function, idiopathic intracranial hypertension, and Leber Hereditary Optic Neuropathy. Dr. Carper completed his residency in neurology at West Virginia University. A native of North Carolina, he takes pleasure in his deep ties to the Mid-Atlantic and Appalachian regions and is privileged to serve the Baltimore area. Dr. Carper is an avid explorer and during his personal time enjoys trying new cuisines, or enjoying the outdoors on a hike or kayaking trip with his family. Dr. Carper is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Oculomotor Apraxia Cogan Type, Increased Intracranial Pressure, Chemosis, and Optic Neuritis.

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal.

Neil R. Miller, M.D., is Professor of Ophthalmology, Neurology & Neurosurgery. He specializes in neuro-ophthalmology and orbital disease. Dr. Miller received his M.D. degree from the Johns Hopkins University School of Medicine and completed his residency in ophthalmology at the Wilmer Eye Institute, where he also served as chief resident. He completed a fellowship in neuro-ophthalmology at the University of CA, San Francisco. He has been a member of the Wilmer faculty since 1976. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Increased Intracranial Pressure, Benign Essential Blepharospasm, Papilledema, Vitrectomy, and Cataract Removal.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy.

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is rated as an Experienced provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.